Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells-Reference-Cited by-同舟云学术

Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells

Published:2020-10-01 Issue:10 Volume:43 Page:1526-1533
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Wang Xin-Yi¹,Sun Gui-Bin²,Wang Ya-Jing³,Yan Fang¹

Affiliation:

1. Department of Pharmaceutical Analysis, School of pharmacology, China Pharmaceutical University

2. Nanjing Syrois Pharmaceutical Co., Ltd.

3. Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/43/10/43_b20-00325/_pdf

Reference54 articles.

1. 1) Foley SB, Hildenbrand ZL, Soyombo AA, Magee JA, Wu Y, Oravecz-Wilson KI, Ross TS. Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia. Cell Reports, 5, 51–60 (2013).

2. 2) Chen M, Gallipoli P, DeGeer D, et al. Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex. J. Natl. Cancer Inst., 105, 405–423 (2013).

3. 3) Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science, 247, 824–830 (1990).

4. 4) Hochhaus A, Kreil S, Corbin AS, La Rosée P, Muller MC, Lahaye T, Hanfstein B, Schoch C, Cross NC, Berger U, Gschaidmeier H, Druker BJ, Hehlmann R. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia, 16, 2190–2196 (2002).

5. 5) Volpe G, Panuzzo C, Ulisciani S, Cilloni D. Imatinib resistance in CML. Cancer Lett., 274, 1–9 (2009).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Natural Products with Anti-Leukemia and Anti-Lymphoma Activities;Mini-Reviews in Medicinal Chemistry;2023-10-06

2. NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia;Oncology Reports;2023-06-16

3. Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms;Biomedicine & Pharmacotherapy;2023-06

4. Stat5 inhibits NLRP3‐mediated pyroptosis to enhance chemoresistance of breast cancer cells via promoting miR‐182 transcription;Chemical Biology & Drug Design;2023-04-18

5. Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy;Biomedicines;2022-07-08